C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.760
-0.010 (-0.36%)
Nov 13, 2026, 4:00 PM EST - Market closed
C4 Therapeutics Employees
C4 Therapeutics had 104 employees as of December 31, 2025. The number of employees decreased by 6 or 5.45% compared to the previous year. That makes C4 Therapeutics the 31,236th largest employer in the world and 3,979th in the United States.
Employees
104
Change (1Y)
-6
Growth (1Y)
-5.45%
Revenue / Employee
$310,356
Profits / Employee
-$875,894
Market Cap
362.44M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 104 | -6 | -5.45% |
| Dec 31, 2024 | 110 | -35 | -24.14% |
| Dec 31, 2023 | 145 | -1 | -0.68% |
| Dec 31, 2022 | 146 | 25 | 20.66% |
| Dec 31, 2021 | 121 | 22 | 22.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CorMedix | 191 |
| Lyell Immunopharma | 161 |
| Alector | 103 |
| Prelude Therapeutics | 79 |
| Rezolute | 63 |
| TRex Bio | 60 |
| Atea Pharmaceuticals | 55 |
| Contineum Therapeutics | 51 |
CCCC News
- 5 days ago - C4 Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 8 days ago - C4 Therapeutics price target lowered to $6 from $7 at Guggenheim - TheFly
- 9 days ago - C4 Therapeutics reports Q3 EPS (16c), consensus (21c) - TheFly
- 9 days ago - C4 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 9 days ago - C4 Therapeutics Quarterly report: Q3 2026 - Filings
- 9 days ago - C4 Therapeutics Earnings release: Q3 2026 - Filings
- 11 days ago - C4 Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 12 days ago - C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire